From 2016 to 2022, parents in the United States have not substantially changed their behavior regarding infant sleeping ...

Clinical characteristics, such as comorbidities or patient behaviors, vary by racial/ethnic group and sex in patients with ...

The US FDA has approved Vtama 1% cream for the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 ...

FDA experts report changes in drug approvals, warnings, and indications for products for use by dermatologists and aesthetic medicine professionals.

The US DOJ has filed a civil complaint against CVS Pharmacy Inc., accusing the chain of unlawfully filling prescriptions for ...

Life expectancy in the United States increased in 2023, reaching 78.4 years, while drug overdose mortality decreased from ...

The US FDA wants to redefine the meaning of healthy food, changing the way food companies can claim their products are indeed ...

There is an association between long-term exposure to ambient air pollution and increased all-cause and cause-specific ...

California Gov. Gavin Newsom declared a public health emergency on Wednesday as bird flu continues to spread among the state’s dairy cattle.

The US FDA has approved Nemluvio (nemolizumab) for the treatment of moderate-to-severe atopic dermatitis in patients aged 12 years and older.

Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.

A new diagnostic test using a dual-biomarker algorithm can inform osteoarthritis diagnosis with high accuracy.